The Kentucky physician fought back against the allegations, but his attorney's arguments were not effective enough to sway the judge. 

A new analysis in Circulation: Cardiovascular Interventions examined rehospitalization rates after AVR, noting that they are consistently associated with worse outcomes and a higher risk of patient mortality.

“This marks a turning point in his ongoing care,” one doctor said in a statement. 

The list represents a collaboration between more than 30 nutritionists, doctors and epidemiologists. 

A survey of nearly 6,000 cardiologists found 1 in 4 experience mental health conditions. 

The American Society of Echocardiography released a new guideline document on the comprehensive use of echocardiography in the diagnosis and therapeutic intervention of rheumatic heart disease.

To address radiation concerns by interventionalists and to help speed workflows in cath labs, Shimadzu released new AI features and single button push features for table and C-arm movement. 

A new study in the Journal of Nuclear Medicine offers insight into how the condition affects the general population, as well as how radiologists can help in the cardiac amyloidosis diagnostic journey.

The FDA is reclassifying interventional cardiovascular implant simulation software into the class II (special controls) regulatory category, which will make it easier for the technology to pass regulatory approval. 

Clyde Yancy, MD, vice dean for diversity and inclusion, chief of cardiology, and a professor of medicine in cardiology and medical social sciences at Northwestern Medicine, discusses health equity issues and how greater inclusion should be a business model because of changing demographics.